There are 2789 resources available
288P - Real-world outcomes and safety of pyrotinib in HER2-positive metastatic breast cancer (MBC) patients: A prospective cohort study
Presenter: Ting Luo
Session: ePoster Display
289P - A retrospective population-based observational study in metastatic HER2-positive breast cancer patients in Denmark previously treated with T-DM1
Presenter: Asbjørn Due
Session: ePoster Display
290P - Treatment with tyrosine kinase inhibitors (TKIs) based therapy in trastuzumab emtansine (T-DM1) resistant HER2-positive metastatic breast cancer: A real-world study
Presenter: Yijia Hua
Session: ePoster Display
219P - Accuracy of MRI to assess response after neoadjuvant chemotherapy according to immunohistochemical breast cancer subtypes: A systematic review and meta-analysis
Presenter: Liselore Maria Janssen
Session: ePoster Display
220P - Hypofractionated radiotherapy for locally advanced stage T4 breast cancer: Safety and efficacy
Presenter: Nadia Nsiri
Session: ePoster Display
221P - Early and late breast cancer recurrence: Differences and the relation with adherence to medical standards
Presenter: Vanya Mitova
Session: ePoster Display
222P - Inflammatory breast cancer: What information we can expect from MRI and how to use it
Presenter: Bibiana Vertakova Krakovska
Session: ePoster Display
223P - Pregnancy-associated breast cancer: A single centre experience
Presenter: Isa Peixoto
Session: ePoster Display
224P - Value of bone scintigraphy in breast cancer patients staged with computed tomography
Presenter: Vladislav Evseev
Session: ePoster Display
338TiP - CAPItello-292: A phase 1b/3 study of capivasertib, palbociclib and fulvestrant versus placebo, palbociclib and fulvestrant in HR+/HER2− advanced breast cancer
Presenter: Erika Hamilton
Session: ePoster Display